
Nektar Therapeutics NKTR
$ 42.82
-3.75%
Annual report 2023
added 03-05-2024
Nektar Therapeutics P/E Ratio 2011-2025 | NKTR
Annual P/E Ratio Nektar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.606 | -0.706 | -3.89 | -7.92 | -8.06 | 10.7 | -133 | -10.7 | -22.3 | -34.5 | -9.99 | -5.68 | -5.38 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.7 | -133 | -17.8 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.92 | $ 1.87 | 11.68 % | $ 477 M | ||
|
Aclaris Therapeutics
ACRS
|
-1.15 | $ 3.0 | -0.99 % | $ 232 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.1 | -0.64 % | $ 7.46 B | ||
|
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Aptorum Group Limited
APM
|
-0.958 | $ 1.1 | -3.51 % | $ 6 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 211.15 | 1.04 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
BioVie
BIVI
|
-0.139 | $ 1.22 | 0.83 % | $ 1.8 M | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
Athersys
ATHX
|
-4.62 | - | 3.77 % | $ 22.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.333 | - | -9.72 % | $ 5.89 M | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-18 | - | -15.15 % | $ 60.3 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 0.17 | -18.84 % | $ 370 M | ||
|
Berkeley Lights
BLI
|
-1.19 | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 95.17 | 0.69 % | $ 27.2 B | ||
|
Catalyst Biosciences
CBIO
|
-0.393 | $ 12.12 | -1.86 % | $ 798 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8.2 | $ 26.86 | -0.96 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Calithera Biosciences
CALA
|
-8.34 | - | -10.95 % | $ 876 K | ||
|
Anika Therapeutics
ANIK
|
-4.51 | $ 9.53 | -0.21 % | $ 140 M | ||
|
Certara
CERT
|
-165 | $ 8.85 | -0.45 % | $ 1.42 B | ||
|
bluebird bio
BLUE
|
-0.316 | - | - | $ 546 M | ||
|
Cellectis S.A.
CLLS
|
-1.62 | $ 4.95 | 4.2 % | $ 116 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.16 | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
106 | $ 583.1 | -0.13 % | $ 44.2 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.55 | 4.08 % | $ 16 M | ||
|
AstraZeneca PLC
AZN
|
706 | $ 92.68 | -0.24 % | $ 96.9 B | ||
|
ChromaDex Corporation
CDXC
|
50.4 | - | -0.88 % | $ 598 M | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
-2 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
12.2 | $ 9.25 | 1.82 % | $ 1.49 B | ||
|
Celldex Therapeutics
CLDX
|
-0.00833 | $ 25.93 | -1.8 % | $ 1.67 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.2 | $ 11.43 | 2.65 % | $ 739 M |